Analysis of methadone and its primary metabolite in meconium

Journal of Analytical Toxicology

Volumn 21, Issue 2, 1997, Pages 154-159

  Stolk, Leo M ^a,b   Coenradie, Saskia M ^b   Smit, Bert J ^b   Van As, Harry L ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ARTICLE; DEMETHYLATION; DRUG URINE LEVEL; FLUORESCENCE POLARIZATION IMMUNOASSAY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; MECONIUM; PRENATAL DRUG EXPOSURE; TOXIN ANALYSIS; URINALYSIS; URINARY EXCRETION;

EID: 0030985576     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/21.2.154     Document Type: Article

References (13)

1. E.M. Ostrea and C.J. Chaves. Perinatal problems (excluding neonatal withdrawal) in maternal drug addiction: A study of 830 cases. J. Pediatr. 94: 292-95 (1979).
2. E.M. Ostrea, M. Brady, S. Gause, A.L. Raymundo, and M. Stevens. Drug screening of newborns by meconium analysis: A large scale prospective epidemiological study. Pediatrics 89: 107-13 (1992).
3. W.E. Wingert, M.S. Feldman, M.H. Kim, L. Noble, I. Hand, and J.J. Yoon. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy. J. Forensic Sci. 39: 150-58 (1994).
4. P. Dahlem, H.U. Bucher, Th. Ursprung, D. Mieth, and K. Gautsch. Nachweis von Drogen in Mekonium. Monatschr Kinderheilkd 140: 354-56 (1992).
5. R.A. Snoeren, A.M.J.A. Duchateau, J.M.H. Conemans, F.D.A. Gerkens, C.C. Pijnenburg, C.G.J. Barella, and R.C.A. Philipse. Systematic toxicological analysis of drugs with HPLC and diode array detection. (Abstract). Pharm Weekbl (Sci) 11: E16 (1989).
6. Clarke's Isolation and Identification of Drugs. A.C. Moffat, Ed. The Pharmaceutical Press, London, U.K., 1986, pp 742-43.
7. E. Anggard, L.M. Gunne, J. Holmstrand, R.E. McMahon, C.G. Sandberg, and H.R. Sullivan. Disposition of methadone in methadone maintenance. Clin. Pharmacol. Ther. 16: 258-66 (1975).
8. J.W. De Vos, P.J. Geerlings, W. van den Brink, J.G.R. Ufkes, and H. van Wilgenburg. Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts. Eur. J. Clin. Pharmacol. 48: 361-66 (1995).
9. G.M. Pacific and R. Nottoli. Placental transfer of drugs administered to the mother. Clin. Pharmacokinet. 28: 235-69 (1995).
10. B. Kraer and P. Dayer. Fetal drug metabolism and its possible clinical implications. Clin. Pharmacokinet. 21: 70-80 (1991).
11. D.K. Knapp, E.M. Ostrea and A. Romero. Fetal exposure to nicotine in passive and active maternal smoking as detected by meconium analysis. J. Pediatr. 124: 471-76 (1994).
12. E.M. Ostrea, D.K. Knapp, L. Tannenbaum, A. Ostrea, A. Romero, M. Montes, and V. Saleri. Serial meconium drug analysis can estimate the chronology and degree of infants in utero drug exposure (Abstract). Pediatr. Res. 33: 229A (1993).
13. M. Mirochnik, D.A. Frank, H. Cabral, A. Turner, and B. Zuckerman. Relation between meconium concentration of the cocaine metabolite benzoylecgonine and fetal growth. J. Pediatr. 126: 636-38 (1995).